NCT00366119View on ClinicalTrials.gov

Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

PHASE4UnknownINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

June 30, 2007

Conditions
Essential Hypertension
Interventions
DRUG

Ramipril

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Pacific Pharmaceuticals

INDUSTRY

NCT00366119 - Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension | Biotech Hunter | Biotech Hunter